The Problem The pharmaceutical and cosmetic landscapes in 2026 are in constant motion, driven by rapid scientific innovation and the absolute imperative of patient safety. With the proliferation of novel therapeutic modalities, ensuring compliance with global regulatory bodies like the FDA, EMA, and ICH is no longer just a legal baseline; it is a fundamental […]


